Search

Your search keyword '"Hudry, Christophe"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Hudry, Christophe" Remove constraint Author: "Hudry, Christophe"
217 results on '"Hudry, Christophe"'

Search Results

1. Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study

2. Évaluation globale standardisée systématique des rhumatismes inflammatoires chroniques : intérêts et limites

3. Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative

4. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

5. 2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis

6. Actualisation 2022 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, incluant le rhumatisme psoriasique

7. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

8. Critères d’évaluation à collecter pour optimiser la prise en charge de routine de la spondyloarthrite axiale : proposition fondée sur des preuves et une rencontre d’experts

9. Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches

11. Evaluation globale standardisée systématique des rhumatismes inflammatoires chroniques: intérêts et limites

17. Collecte et prise en charge de certaines comorbidités et facteurs de risque associés dans le cadre des rhumatismes inflammatoires chroniques dans la pratique quotidienne en France

20. Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France

25. Erratum to “2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis” [Joint Bone Spine 2022;89:105344]

26. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire

28. The initial ActConnect study was supported by unrestricted academic grants from

34. Additional file 1 of Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients

36. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

39. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

40. Physical activity and barriers and facilitators in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients

42. Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study

45. Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings.

46. Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

48. MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE.

49. At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials

50. At which point and for which reasons are oral MTX formulations switched to injectable ones in RA patients? combined results from 3 independent observational and clinical trials

Catalog

Books, media, physical & digital resources